Metabolic
Tesamorelin
A clinically validated GHRH analogue with one of the strongest evidence bases in its class. Tesamorelin is a stabilised synthetic analogue of GHRH, the hormone that signals the pituitary gland to release growth hormone. Rather than introducing synthetic GH directly, it works with the body's own signalling system to produce natural, pulsatile GH release that mirrors physiological rhythm. Studies have demonstrated significant reductions in visceral adipose tissue, improved lipid profiles, and measurable IGF-1 elevation without the side effect profile associated with direct GH administration. One of the most well-characterised GH-axis compounds available. The 10mg pen suits standard GH-axis research protocols. The 40mg pen is designed for extended cycles requiring higher cumulative dosing.
€79.90 · 10mg
Available options
Product information
A clinically validated GHRH analogue with one of the strongest evidence bases in its class. Tesamorelin is a stabilised synthetic analogue of GHRH, the hormone that signals the pituitary gland to release growth hormone. Rather than introducing synthetic GH directly, it works with the body's own signalling system to produce natural, pulsatile GH release that mirrors physiological rhythm. Studies have demonstrated significant reductions in visceral adipose tissue, improved lipid profiles, and measurable IGF-1 elevation without the side effect profile associated with direct GH administration. One of the most well-characterised GH-axis compounds available. The 10mg pen suits standard GH-axis research protocols. The 40mg pen is designed for extended cycles requiring higher cumulative dosing.